Baldwin Investment Management’s Globus Medical GMED Stock Holding History

Baldwin Investment Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,090	Closed	-$229K	–	204
2022 Q4	$229K	Buy	+3,090	New	+$210K	0.04%	186
2022 Q2	–	Sell	-5,815	Closed	-$429K	–	219
2022 Q1	$429K	Hold	5,815	–	–	0.06%	174
2021 Q4	$420K	Buy	5,815 +715	+14%	+$51.9K	0.07%	179
2021 Q3	$391K	Hold	5,100	–	–	0.07%	182
2021 Q2	$395K	Sell	5,100 -95	-2%	-$6.75K	0.07%	180
2021 Q1	$320K	Buy	5,195 +345	+7%	+$21.8K	0.06%	200
2020 Q4	$316K	Buy	4,850 +525	+12%	+$30.2K	0.06%	181
2020 Q3	$214K	Buy	+4,325	New	+$223K	0.05%	198

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Baldwin Investment Management's GMED Position: Q1 2023 in Review

Baldwin Investment Management sold out of Globus Medical (GMED) in Q1 2023, closing a stake of 3,090 shares — an estimated $229K sold.

Baldwin Investment Management first reported a position in GMED in Q3 2020 and held it in 8 quarters. The position peaked at $429K in Q1 2022. 389 funds tracked by Wall St. Rank hold GMED as of Q1 2023.

Baldwin Investment Management reported no remaining Globus Medical position as of Q1 2023 after selling out during the quarter.
Baldwin Investment Management sold 3,090 Globus Medical shares in Q1 2023, an estimated $229K.
Baldwin Investment Management first reported a position in Globus Medical in Q3 2020 and held it in 8 quarters.
Baldwin Investment Management's Globus Medical position peaked at $429K in Q1 2022.
389 funds tracked by Wall St. Rank held Globus Medical as of Q1 2023.

Based on Baldwin Investment Management's 13F filing for Q1 2023, filed 15 May 2023.